Activation of TLR2 and TLR4 by minimally modified low-density lipoprotein in human macrophages and monocytes triggers the inflammatory response

Human Immunology

Volumn 71, Issue 8, 2010, Pages 737-744

  Chavez Sanchez L ^a,b   Madrid Miller, A ^b   Chavez Rueda K ^a   Legorreta Haquet, M V ^a   Tesoro Cruz, E ^a   Blanco Favela, F ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b HOSPITAL DE CARDIOLOGÍA   (Mexico)

Author keywords

LDL; Macrophage; Monocyte; TNF ; Toll like receptors

Indexed keywords

CD14 ANTIGEN; LOW DENSITY LIPOPROTEIN; MINIMALLY MODIFIED LOW DENSITY LIPOPROTEIN; MONOCLONAL ANTIBODY; RECEPTOR BLOCKING AGENT; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ANTIBODY SPECIFICITY; ARTICLE; CELL SURFACE; CELL TYPE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; INFLAMMATION; MACROPHAGE; MALE; MONOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEIN SYNTHESIS INHIBITION; RECEPTOR UPREGULATION;

ADULT; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ANTIGENS, CD14; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; INFLAMMATION MEDIATORS; LIPOPROTEINS, LDL; MACROPHAGES; MALE; MICROSCOPY, CONFOCAL; MONOCYTES; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA; U937 CELLS; YOUNG ADULT;

EID: 77954760594     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2010.05.005     Document Type: Article

References (32)

1. Libby P. Inflammation in atherosclerosis. Nature 2002, 420:868-874.
2. Jiang Q., Akashi S., Miyake K., Petty H.R. Lipopolysaccharide induces physical proximity between CD14 and Toll-like receptor 4 (TLR4) prior to nuclear translocation of NF-kappa B. J Immunol 2000, 165:3541-3544.
3. Uematsu S., Akira S. Toll-like receptors and innate immunity. J Mol Med 2006, 9:712-725.
4. Bannered A., Gerondakis S. Coordinating TLR-activated signaling pathways in cells of the immune system. Immunol Cell Biol 2007, 85:420-424.
5. Edfeldt K., Swedenborg J., Hansson G.K., Yan Z.Q. Expression of Toll-like receptors in human atherosclerotic lesions. A possible pathway for plaque activation. Circulation 2002, 105:1158-1161.
6. Xu X.H., Shah P.K., Faure E., Equils O., Thomas L., Fishbein M.C., et al. Toll-like receptor-4 is expressed by macrophages in murine and human lipid rich atherosclerotic plaques and upregulated by oxidized LDL. Circulation 2001, 104:3103-3108.
7. Kusumoto S., Katus H.A., Heine H. TLR4-mediated inflammatory activation of human coronary artery endothelial cells by LPS. Cardiovasc Res 2002, 1:126-134.
8. Yumoto H., Chou H.H., Takahashi Y., Davey M., Gibson F.C., Genco C.A. Sensitization of human aortic endothelial cells to lipopolysaccharide via regulation of Toll-like receptor 4 by bacterial fimbria-dependent invasion. Infect Immun 2005, 73:8050-8059.
9. Cao F., Castrillo A., Tontonoz P., Re F., Byrne G.I. Chlamydia pneumoniae induced macrophage foam cell formation is mediated by Toll-like receptor 2. Infect Immum 2007, 2:753-759.
10. Liu X., Ukai T., Yumoto H., Davey M., Giswami S., Gibson F.C., et al. Toll-like receptor 2 plays a critical role in the progression of atherosclerosis that is independent of dietary lipids. Atherosclerosis 2008, 196:146-154.
11. Miller Y.I., Viriyakosol S., Binder C.J., Feramisco J.R., Kirkland T.N., Witztum J.L. Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4/MD-2, and inhibits phagocytosis of apoptotic cells. J Biol Chem 2003, 278:1561-1568.
12. Miller Y.I., Viriyakosol S., Worrall D.S., Boullier A., Butler S., Witztum J.L. Toll-like receptor 4-dependent and -independent cytokine secretion induced by minimally oxidized low-density lipoprotein in macrophages. Arterioscler Thromb Vasc Biol 2005, 25:1213-1219.
13. Pentikainen M.O., Lindsted K.A., Kovanen P.T. Inhibition of the oxidative modification of LDL by nitecapone. Arterioscler Thromb Vasc Biol 1995, 15:740-747.
14. Mullick A.E., Tobias P.S., Curtiss L.K. Modulation of atherosclerosis in mice by Toll-like receptor 2. J Clin Invest 2005, 115:3149-3156.
15. Michelsen K.S., Wong M.H., Shah P.K., Zhang W., Yano J., Doherty T.M., et al. Lack of Toll-like receptor 4 or mice deficient in apolipoprotein E. Proc Natl Acad Sci U S A 2004, 101:10685-10690.
16. Shuto T., Kato K., Mori Y., Viriyakosol S., Oba M., Furuta T., et al. Membrane-anchored CD14 is required for LPS-induced TLR4 endocytosis in TLR4/MD-2/CD14 overexpressing CHO cells. Biochem Biophys Res Commun 2005, 338:1402-1409.
17. Li X., Bradford B.U., Dalldorf F., Goyert S.M., Stimpson S.A., Thurman R.G., Makarov S.S. CD14 mediates the innate immune responses to arthritopathogenic peptidoglycan-polysaccharide complexes of Gram-positive bacterial cell walls. Arthritis Res Ther 2004, 6:R273-R281.
18. Metkar S., Awasthi S., Denamur E., Kim K.S., Gangloff S.C., Teichberg S., et al. Role of CD14 in responses to clinical isolates of Escherichia coli: Effects of K1 capsule expression. Infect Immun 2007, 11:5415-5424.
19. Pasini A.F., Anselmi M., Garbin U., Franchi E., Stranieri C., Nava M.C., et al. Enhance levels of oxidized low-density lipoprotein prime monocytes to cytokine overproduction via upregulation of CD14 and Toll-like receptor 4 in unstable angina. Arterioscler Thromb Vasc Biol 2007, 27:1991-1997.
20. Janeway C.A., Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002, 20:197-216.
21. Netea M.G., Nold-Petry C.A., Nold M.F., Joosten L.A., Opitz B., van der Meer J.H., et al. Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages. Blood 2009, 113:2324-2335.
22. Roelofs M.F., Boelens W.C., Joosten L.A., Abdollahi-Roodzas S., Geurts J., Wunderink L.U., et al. Identification of small heat shock protein B8 (HSP22) as a novel TLR4 ligand and potential involvement in the pathogenesis of rheumatoid arthritis. J Immunol 2006, 176:7021-7027.
23. Hodgkinson C.P., Laxton R.C., Patel K., Ye S. Advanced glycation end product of low density lipoprotein activates the Toll like 4 receptor pathway implications for diabetic atherosclerosis. Arterioscler Thromb Vasc Biol 2008, 28:2275-2281.
24. Kaisho T., Akira S. Pleiotropic function of Toll-like receptors. Microbes Infect 2004, 15:1388-1394.
25. Schoneveld A.H., Hoefer I., Sluijter J.P., Laman J.D., de Kleijn D.P., Pasterkamp G. Atherosclerotic lesion development and Toll like receptor 2 and 4 responsiveness. Atherosclerosis 2008, 197:95.
26. + blood monocytes and synovial tissue macrophages in rheumatoid arthritis. Arthritis Rheum 2004, 50:1457-1467.
27. Zmijewski J.W., Lorne E., Zhao X., Tsuruta Y., Sha Y., Liu G., Abraham E. Antiinflammatory effects of hydrogen peroxide in neutrophil activation and acute lung injury. Am J Respir Crit Care Med 2009, 179:694.
28. Vitseva O.I., Tanriverdi K., Tchkonia T.T., Kirkland J.L., McDonnell M.E., Apovian C.M., et al. Inducible Toll-like receptor and NF-kappaB regulatory pathway expression in human adipose tissue. Obesity 2008, 16:932-937.
29. Netea M.G., Kullberg B.J., Demacker P.N., Jacobs L.E., Verver-Jansen T.J., Hijmans A., et al. Native LDL potentiate TNF alpha and IL-8 production by human mononuclear cells. J Lipid Res 2002, 43:1065-1071.
30. Vabulas R.M., Ahmad-Nejad P., da Costa C., Miethke T., Kirschning C.J., Hacker H., Wagner H. Endocytosed HSP60s use Toll-like receptor 2 (TLR2) and TLR4 to activate the Toll/interleukin-1 receptor signaling pathway in innate immune cells. J Biol Chem 2001, 276:31332-31339.
31. Wolf G., Bohlender J., Bondeva T., Roger T., Thaiss F., Wenzel U.O. Angiotensin II upregulates Toll-like receptor 4 on mesangial cells. J Am Soc Nephrol 2006, 17:1585-1593.
32. Fan J., Li Y., Vodovotz Y., Billiar T.R., Wilson M.A. Hemorrhagic Schock-activated neutrophils augment TLR4 signaling-induced TLR2 upregulation in alveolar macropahges: Role in hemorrhage-primed lung inflammation. Am J Physiol Lung Cell Mol Physiol 2006, 290:L738-L746.